Binding Mode of Actin-Aplyronine A-Tubulin Heterotrimeric Complex Revealed by Molecular Dynamics Simulation

被引:6
作者
Utomo, Didik Huswo [1 ]
Kita, Masaki [1 ]
机构
[1] Nagoya Univ, Grad Sch Bioagr Sci, Furo Cho,Chikusa Ku, Nagoya, Aichi 4648601, Japan
关键词
Protein-protein interactions; Molecular dynamics simulation; Antitumor agents; POTENT ANTITUMOR SUBSTANCE; PROTEIN-PROTEIN INTERACTIONS; MARINE ORIGIN; CONFORMATIONAL-CHANGES; MACROLIDE APLYRONINE; CYTOTOXICITY; MICROTUBULES; DERIVATIVES; CHEMISTRY; KINESIN;
D O I
10.1246/bcsj.20220299
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The antitumor macrolide aplyronine A (ApA) disturbs microtubule (MT) dynamics by inducing the protein -protein interaction (PPI) between actin and tubulin. However, the detailed binding mode of the actin-ApA-tubulin heterotrimeric complex (HTC) and the molecular mechanism by which ApA inhibits MT are unclear. To establish the binding modes of the actin-ApA complex on the tubulin alpha/beta-heterodimer, blind protein -protein docking and molecular dynamics simulations were performed. Two plausible HTC models having enough conformational and ligand stabilities were obtained, in which the C7 N,N,O-trimethylserine ester of ApA, an essential group for its potent cytotoxicity and PPI-inducing effect, interacted with Glu336/Asn337 or Arg123/Glu127 of beta-tubulin. Based on the superposed models with the MT lattice, two possible mechanisms were proposed: the HTC would bind to the plus end of MT to potently inhibit tubulin assembly, or the actin- ApA complex would bind to the middle part of MT to form the internal HTC and destabilize MT structure. Our proposed models can explain why the actin-ApA complex inhibits MT dynamics at a much lower concentration than those of fibrous actin and tubulin proteins in cells.
引用
收藏
页码:120 / 126
页数:7
相关论文
共 35 条
[1]  
[Anonymous], The PyMOL Molecular Graphics System, Version 2.5.5 Schrodinger
[2]   Functional antibody characterization via direct structural analysis and information-driven protein-protein docking [J].
Depetris, Rafael S. ;
Lu, Dan ;
Polonskaya, Zhanna ;
Zhang, Zhikai ;
Luna, Xenia ;
Tankard, Amari ;
Kolahi, Pegah ;
Drummond, Michael ;
Williams, Chris ;
Ebert, Maximilian C. C. J. C. ;
Patel, Jeegar P. ;
Poyurovsky, Masha, V .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2022, 90 (04) :919-935
[3]   Synthesis and Biological Activities of Aplyronine A Analogues toward the Development of Antitumor Protein-Protein Interaction Inducers between Actin and Tubulin: Conjugation of the C1-C9 Macrolactone Part and the C24-C34 Side Chain [J].
Futaki, Kentaro ;
Takahashi, Momoko ;
Tanabe, Kenta ;
Fujieda, Akari ;
Kigoshi, Hideo ;
Kita, Masaki .
ACS OMEGA, 2019, 4 (05) :8598-8613
[4]   Protein-Ligand Blind Docking Using QuickVina-W With Inter-Process Spatio-Temporal Integration [J].
Hassan, Nafisa M. ;
Alhossary, Amr A. ;
Mu, Yuguang ;
Kwoh, Chee-Keong .
SCIENTIFIC REPORTS, 2017, 7
[5]   Structure basis for antitumor effect of aplyronine A [J].
Hirata, K ;
Muraoka, S ;
Suenaga, K ;
Kuroda, T ;
Kato, K ;
Tanaka, H ;
Yamamoto, M ;
Takata, M ;
Yamada, K ;
Kigoshi, H .
JOURNAL OF MOLECULAR BIOLOGY, 2006, 356 (04) :945-954
[6]   Analysis of the aplyronine A-induced protein-protein interaction between actin and tubulin by surface plasmon resonance [J].
Hirayama, Yuichiro ;
Yamagishi, Kota ;
Suzuki, Tomohiro ;
Kawagishi, Hirokazu ;
Kita, Masaki ;
Kigoshi, Hideo .
BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (12) :2809-2814
[7]   Protein-protein docking tested in blind predictions: the CAPRI experiment [J].
Janin, Joel .
MOLECULAR BIOSYSTEMS, 2010, 6 (12) :2351-2362
[8]   Microtubules as a target for anticancer drugs [J].
Jordan, MA ;
Wilson, L .
NATURE REVIEWS CANCER, 2004, 4 (04) :253-265
[9]   Cytotoxicity and actin-depolymerizing activity of aplyronine A, a potent antitumor macrolide of marine origin, and its analogs [J].
Kigoshi, H ;
Suenaga, K ;
Takagi, M ;
Akao, A ;
Kanematsu, K ;
Kamei, N ;
Okugawa, Y ;
Yamada, K .
TETRAHEDRON, 2002, 58 (06) :1075-1102
[10]   Aplyronine A, a potent antitumor substance of marine origin, aplyronines B and C, and artificial analogues: Total synthesis and structure-cytotoxicity relationships [J].
Kigoshi, H ;
Suenaga, K ;
Mutou, T ;
Ishigaki, T ;
Atsumi, T ;
Ishiwata, H ;
Sakakura, A ;
Ogawa, T ;
Ojika, M ;
Yamada, K .
JOURNAL OF ORGANIC CHEMISTRY, 1996, 61 (16) :5326-5351